Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (NCT07823751) titled 'The Role of Bisphosphonate and Simvastatin Combination on Therapeutic Response in Breast Cancer With Bone Metastasis Via Dicckopf-1 Pathway' on Sept. 8.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Triple (Participant, Care Provider, Investigator).
Primary Sponsor: Universitas Indonesia
Condition:
Breast Cancer With Bone Metastasis
Intervention:
Drug: Simvastatin
Drug: Placebo
Recruitment Status: Not recruiting
Phase: N/A
Date of First Enrollment: April 10, 2021
Target Sample Size: 35
Countries of Recruit...